×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Bear of the Day: NeoGenomics (NEO)
Yahoo News Singapore
NeoGenomics NEO is a $5.3 billion provider of clinical laboratory services that specializes in cancer genetics and diagnostic testing,...
2 days ago
NeoGenomics, Inc. (NASDAQ:NEO) Given Consensus Recommendation of "Moderate Buy" by Brokerages
MarketBeat
Shares of NeoGenomics, Inc. (NASDAQ:NEO - Get Free Report) have been given an average rating of "Moderate Buy" by the eleven research firms...
24 hours ago
NeoGenomics Reports First Quarter 2024 Results
Business Wire
NeoGenomics, Inc. announced its first-quarter results for the period ended March 31, 2024.
2 weeks ago
NeoGenomics and Herc saw revenue growth in the first quarter over the year
Naples Daily News
Herc and NeoGenomics are among a handful of publicly-traded companies in SWFL. Both saw revenue growth in the first quarter of 2024.
2 weeks ago
Where NeoGenomics Stands With Analysts - NeoGenomics (NASDAQ:NEO)
Benzinga
Ratings for NeoGenomics. NEO+1.94%. + Free Alerts. were provided by 4 analysts in the past three months, showcasing a mix of bullish and...
2 weeks ago
NeoGenomics: Q1 Earnings Snapshot
qz.com
FORT MYERS, Fla. (AP) — FORT MYERS, Fla. (AP) — NeoGenomics Inc. (NEO) on Tuesday reported a loss of $27.1 million in its first quarter.
2 weeks ago
Investors Interested In NeoGenomics, Inc.'s (NASDAQ:NEO) Revenues
Simply Wall St
NeoGenomics. NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. ... Mediocre...
1 month ago
NeoGenomics faces setback, will appeal ruling in patent fight over test
The News-Press
The court order allows NeoGenomics to continue offering RaDaR to patients who are already using it, and to continue utilizing it for clinical...
4 months ago
NeoGenomics (NEO) Reports Q1 Loss, Tops Revenue Estimates
Yahoo Movies Canada
NeoGenomics (NEO) delivered earnings and revenue surprises of -500.00% and 2.62%, respectively, for the quarter ended March 2021.
3 days ago
NeoGenomics (NASDAQ:NEO) Stock Crosses Below 200 Day Moving Average of $16.05
MarketBeat
Shares of NeoGenomics, Inc. (NASDAQ:NEO - Get Free Report) passed below its 200-day moving average during trading on Monday .
1 day ago